Trends in Cannabis-Related Hospitalizations in Arizona From 2016 to 2021 and Associations With Mental Health-Related Hospitalizations
- PMID: 39330945
- PMCID: PMC12081169
- DOI: 10.15288/jsad.23-00379
Trends in Cannabis-Related Hospitalizations in Arizona From 2016 to 2021 and Associations With Mental Health-Related Hospitalizations
Abstract
Objective: The purpose of this study was to examine trends in cannabis-related hospital visits in Arizona from 2016 to 2021 and associations with hospital visits for a mental health condition.
Method: Data were emergency department and inpatient hospital discharge records from all Arizona licensed hospitals from 2016 to 2021. Records comprised 18,758,614 hospital visits. Cannabis-related visits were defined by International Classification of Diseases (ICD) diagnostic codes for cannabis use (unspecified use, abuse, dependence) or poisoning. Mental health visits were defined by ICD diagnostic codes for mental health conditions.
Results: The rate of cannabis-related hospital visits increased from 1,301.50 per 100,000 visits in 2016 to 1,565.54 per 100,000 visits in 2021, a 20% increase. The increase was larger for visits by adolescents and older adults ages 65+: 63.94% and 84.45%, respectively. Cannabis-related visits were 7.75 (95% CI [7.69, 7.81]) times as likely as visits unrelated to cannabis to have a mental health condition as the primary diagnosis from 2016 to 2021 and were 2.32 (95% CI [2.30, 2.34]) times as likely after adjustment for covariates, including alcohol and other substance-related diagnoses. The association between cannabis-related visits and mental health-related visits increased each year, particularly for older adults ages 65+.
Conclusions: The rate of cannabis-related hospital visits is increasing, as is the cannabis-related risk of a hospital visit for a mental health condition. The increases are especially pronounced among hospital visits by older adults (ages 65+), highlighting the need for prevention and intervention in this under-recognized at-risk group.
Conflict of interest statement
The authors have no conflicts to declare.
Similar articles
-
Trends in cannabis-attributable hospitalizations and emergency department visits: data from the Canadian Substance Use Costs and Harms Study (2007-2020).Health Promot Chronic Dis Prev Can. 2025 Jun;45(6):265-276. doi: 10.24095/hpcdp.45.6.01. Health Promot Chronic Dis Prev Can. 2025. PMID: 40504124 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality.JAMA Netw Open. 2025 Feb 3;8(2):e2457852. doi: 10.1001/jamanetworkopen.2024.57852. JAMA Netw Open. 2025. PMID: 39913138 Free PMC article.
-
Pediatric Hospitalizations and Emergency Department Visits Related to Mental Health Conditions and Self-Harm.JAMA Netw Open. 2024 Oct 1;7(10):e2441874. doi: 10.1001/jamanetworkopen.2024.41874. JAMA Netw Open. 2024. PMID: 39470637 Free PMC article.
-
Psychosocial interventions for cannabis use disorder.Cochrane Database Syst Rev. 2016 May 5;2016(5):CD005336. doi: 10.1002/14651858.CD005336.pub4. Cochrane Database Syst Rev. 2016. PMID: 27149547 Free PMC article.
References
-
- Azofeifa A., Mattson M. E., Fogarty K., Lyerla R. Characterizing Marijuana Use Disorders (DSM-5) — National Survey on Drug Use and Health, United States, 2020. International Journal of Mental Health and Addiction. 2023 doi: 10.1007/s11469-023-01137-4. - DOI
-
- Bahji A., Kaur S., Devoe D., Patten S. Trends in Canadian cannabis consumption over time: A two-step meta-analysis of Canadian household survey data. Canadian Journal of Addiction. 2022;13(3):6–13. doi: 10.1097/cxa.0000000000000154. - DOI
-
- Black N., Stockings E., Campbell G., Tran L. T., Zagic D., Hall W. D., Farrell M., Degenhardt L. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. The Lancet Psychiatry. 2019;6(12):995–1010. doi: 10.1016/s2215-0366(19)30401-8. - DOI - PMC - PubMed
-
- Callaghan R. C., Sanches M., Vander Heiden J., Kish S. J. Impact of Canada's cannabis legalisation on youth emergency department visits for cannabis-related disorders and poisoning in Ontario and Alberta, 2015–2019. Drug and Alcohol Review. 2023;42(5):1104–1113. doi: 10.1111/dar.13637. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical